[EN] HISTONE DEACETYLASE INHIBITORS<br/>[FR] INHIBITEURS DE L'HISTONE DÉSACÉTYLASE
申请人:MERCK & CO INC
公开号:WO2006017216A1
公开(公告)日:2006-02-16
This invention relates to hydroxamic acid derivatives having a urea linkage, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.
这项发明涉及具有脲键的羟羟基脂肪酸衍生物,这些衍生物是组蛋白去乙酰化酶(HDAC)的抑制剂,可用于预防和/或治疗细胞增殖性疾病,例如癌症、自身免疫、过敏和炎症性疾病,中枢神经系统(CNS)疾病如神经退行性疾病,以及预防和/或治疗再狭窄。